Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

8,441 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,766
Recruiting: 1,006
Ph III recruiting: 98
Growth YoY: −4.7%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.7%
Trials / 1,000 deaths: 74.9 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,353)

clinicaltrialsPublishedShowing 751–800 of 8,441 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02416388	Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR(BIG-1)	recruiting	Phase 2 / Phase 3	3,100	University Hospital, AngersOTHER_GOV	1	Jul 17, 2026	clinicaltrials
NCT03480360	Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression	completed	Phase 3	21	Dartmouth-Hitchcock Medical Center